Long-term safety and efficacy of anti-TNF multivalent VHH antibodies ozoralizumab in patients with rheumatoid arthritis

Authors

Institutions

Publication Details

Journal
RMD Open
Published
2024-08-01
DOI
https://doi.org/10.1136/rmdopen-2024-004480
Citations
9
Primary Topic
Chronic Lymphocytic Leukemia Research
Type
article
Field-Weighted Citation Impact
3.94

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Long-term safety and efficacy of anti-TNF multivalent VHH antibodies ozoralizumab in patients with rheumatoid arthritis

Masafumi Kawanishi, Yoshiya Tanaka, Hironori Yamasaki, Tsutomu Takeuchi et al.
9 citations
RMD Open
Chronic Lymphocytic Leukemia Research
3.94
article

Long-term safety and efficacy of anti-TNF multivalent VHH antibodies ozoralizumab in patients with rheumatoid arthritis

Masafumi Kawanishi, Yoshiya Tanaka, Hironori Yamasaki, Tsutomu Takeuchi, Yusuke Miyazaki
article en
9 citations

Abstract

No abstract available for this paper.
RMD OpenVol. 10(3)
University of Occupational and Environmental Health Japan (JP), Keio University (JP), Taisho Pharmaceutical (Japan) (JP), Saitama Medical University (JP)
Sanofi, Ablynx
Good health and well-being
Openalex Percentile: Top 6%
Chronic Lymphocytic Leukemia Research
3.94
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.